Status: Recruiting
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
The study will evaluate the detection of tumor-antigen specific immune cells in cancer patients in whom the role of the immune system is suspected.
Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Institut CurieUpdated: May 6, 2026Locations: 2
Eligibility criteria
Patient aged 18 or over, [+8]
Inability to undergo study follow-up for geographical, social or psychological r... [+6]